TY - JOUR
T1 - Later paternal age and sex differences in schizophrenia symptoms
AU - Rosenfield, Paul J.
AU - Kleinhaus, Karine
AU - Opler, Mark
AU - Perrin, Mary
AU - Learned, Nicole
AU - Goetz, Raymond
AU - Stanford, Arielle
AU - Messinger, Julie
AU - Harkavy-Friedman, Jill
AU - Malaspina, Dolores
N1 - Funding Information:
This work was supported by NARSAD (DM) and by the National Institutes of Health to 1R01 MH059114 (DM) and K24 MH001699 (DM). NARSAD and the NIMH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
PY - 2010/2
Y1 - 2010/2
N2 - Objective: Advanced paternal age is consistently associated with an increased risk for schizophrenia, accounting for up to a quarter of cases in some populations. If paternal age-related schizophrenia (PARS) involves a distinct etiopathology, then PARS cases may show specific characteristics, vis-à-vis other schizophrenia cases. This study examined if PARS exhibits the symptom profile and sex differences that are consistently observed for schizophrenia in general, wherein males have an earlier onset age and more severe negative symptoms than females. Method: Symptoms were assessed at baseline (admission) and during medication-free and treatment phases for 153 inpatients on a schizophrenia research unit, 38 of whom fulfilled operationally defined criteria for PARS (sporadic cases with paternal age ≥ 35). Results: Males and females with PARS had the same age at onset and a similar preponderance of negative symptoms, whereas the other (non-PARS) cases showed the typical earlier onset age and more severe negative symptoms in males. When medications were withdrawn, PARS cases showed significantly worse symptoms than non-PARS cases (higher total PANSS scores and positive, activation, and autistic preoccupation scores). However these symptoms globally improved with antipsychotic treatment, such that the differences between the PARS and other schizophrenia cases receded. Conclusion: The lack of sex differences in the age at onset and the greater severity of medication-free symptoms bolster the hypothesis that PARS has a distinct etiopathology. It also suggests that female sex does not exert a protective effect on the course of PARS, as it may in other forms of schizophrenia.
AB - Objective: Advanced paternal age is consistently associated with an increased risk for schizophrenia, accounting for up to a quarter of cases in some populations. If paternal age-related schizophrenia (PARS) involves a distinct etiopathology, then PARS cases may show specific characteristics, vis-à-vis other schizophrenia cases. This study examined if PARS exhibits the symptom profile and sex differences that are consistently observed for schizophrenia in general, wherein males have an earlier onset age and more severe negative symptoms than females. Method: Symptoms were assessed at baseline (admission) and during medication-free and treatment phases for 153 inpatients on a schizophrenia research unit, 38 of whom fulfilled operationally defined criteria for PARS (sporadic cases with paternal age ≥ 35). Results: Males and females with PARS had the same age at onset and a similar preponderance of negative symptoms, whereas the other (non-PARS) cases showed the typical earlier onset age and more severe negative symptoms in males. When medications were withdrawn, PARS cases showed significantly worse symptoms than non-PARS cases (higher total PANSS scores and positive, activation, and autistic preoccupation scores). However these symptoms globally improved with antipsychotic treatment, such that the differences between the PARS and other schizophrenia cases receded. Conclusion: The lack of sex differences in the age at onset and the greater severity of medication-free symptoms bolster the hypothesis that PARS has a distinct etiopathology. It also suggests that female sex does not exert a protective effect on the course of PARS, as it may in other forms of schizophrenia.
KW - Genetics
KW - Heterogeneity
KW - Negative symptoms
KW - Positive symptoms
UR - http://www.scopus.com/inward/record.url?scp=74449089548&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2009.10.020
DO - 10.1016/j.schres.2009.10.020
M3 - Article
C2 - 19926452
AN - SCOPUS:74449089548
SN - 0920-9964
VL - 116
SP - 191
EP - 195
JO - Schizophrenia Research
JF - Schizophrenia Research
IS - 2-3
ER -